甲硝唑与阿莫西林的不良事件:五项随机临床试验大型数据集的回顾性分析
该回顾性分析评估了五项随机临床试验中656名受试者使用甲硝唑(MTZ)联合阿莫西林(AMX)辅助牙周治疗后不良事件的发生频率及其与患者特征的关系。抗生素组不良事件频率范围为1.0%至17.7%,安慰剂组为0.9%至13.7%,腹泻和金属味在抗生素组更常见(p < .05)。糖尿病及在愈合期而非活动期使用抗生素是报告不良事件的主要危险因素,≤49岁女性和女性也倾向于报告更多副作用。
要点
- MTZ+AMX治疗期间副作用发生率从少见(1%)到非常常见(17.7%)。
- 抗生素组较安慰剂组更常见腹泻和金属味(p < .05)。
- 糖尿病及愈合期使用抗生素是报告不良事件的主要危险因素。
核心结论
- MTZ+AMX治疗期间副作用发生率从少见(1%)到非常常见(17.7%)。
- 增加患者报告不良事件的主要因素是糖尿病和在愈合期而非活动期使用抗生素。
- ≤49岁患者和女性也倾向于报告更多副作用。
研究设计与样本
- 回顾性分析五项测试MTZ+AMX辅助机械治疗的随机临床试验数据。
- 共评估656名受试者的信息,志愿者回答不良事件问卷。
主要发现
- 抗生素组副作用频率范围为1.0%至17.7%,安慰剂组为0.9%至13.7%。
- 抗生素组较安慰剂组更常观察到腹泻和金属味(p < .05)。
- 糖尿病显著提高患者报告不适(OR=2.6)、腹泻(OR=4.0)、乏力(OR=6.0)和过度嗜睡(OR=2.9)的比值比。
- 在全身健康志愿者中,机械治疗后3个月(愈合期)使用抗生素(OR=3.0)、女性(OR=3.9)和年龄≤49岁(OR=4.5)显著增加报告不良事件的机会。
关键数值与推荐
- 抗生素组副作用频率范围为1.0%至17.7%,安慰剂组为0.9%至13.7%。
- 糖尿病:不适OR=2.6,腹泻OR=4.0,乏力OR=6.0,过度嗜睡OR=2.9。
- 全身健康志愿者:愈合期使用抗生素OR=3.0,女性OR=3.9,年龄≤49岁OR=4.5。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To evaluate the frequency of side effects associated with intake of metronidazole (MTZ) + amoxicillin (AMX) in periodontal treatment, and to explore associations between these events and patients' features. MATERIALS AND METHODS: Data of five randomized clinical trials testing MTZ + AMX adjunctive to mechanical therapy were evaluated. Volunteers answered an adverse event questionnaire. RESULTS: Information from 656 subjects was assessed. The frequency of side effects in the antibiotic- and placebo-treated groups ranged from 1.0% to 17.7% and 0.9% to 13.7%, respectively. The events more frequently observed in the antibiotic than in the placebo group were diarrhoea and metallic taste (p < .05). Diabetes significantly raised the odds of a patient reporting discomfort (odds ratio [OR] = 2.6), diarrhoea (OR = 4.0), weakness (OR = 6.0) and excessive sleepiness (OR = 2.9). In systemically healthy volunteers, using antibiotics 3 months post-mechanical treatment (healing phase) (OR = 3.0), being a woman (OR = 3.9) and aged ≤49 (OR = 4.5) significantly increased the chances of reporting adverse events. CONCLUSIONS: The occurrence of side effects during MTZ + AMX treatment ranged from uncommon (1%) to very common (17.7%). The main factors raising the chances of a patient reporting adverse events were diabetes and taking antibiotics in the healing phase, instead of in the active phase of treatment. Patients ≤ 49 years old and females also tend to report more side effects.
引用
- Retamal-Valdes B, Tavares APL, Monique S, et al. Adverse events of metronidazole and amoxicillin: Retrospective analysis of a large data set of five randomized clinical trials. J Clin Periodontol. 2022. PMID: 35851689. doi:10.1111/jcpe.13704
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。